Hory B, Rozenbaum A, Bosset J F, Flesch M, Carbillet J P, Lenys R, Leconte Des Floris R
Sem Hop. 1981;57(33-36):1386-91.
The authors studied the prognosis of 66 adults NHL according to: histological, clinical, biological and evolution criteria. The patients were treated by polychemotherapy or polychemo-and radiotherapy. Three years actuarial survival compared by the X2 test permits to consider only two independent prognostic factors: histologic type and complete remission due to treatment.
作者根据组织学、临床、生物学和病情演变标准对66例成人非霍奇金淋巴瘤患者的预后进行了研究。患者接受了多药化疗或多药化疗联合放疗。通过X²检验比较三年精算生存率，结果表明只有两个独立的预后因素：组织学类型和治疗导致的完全缓解。
